PreciseDx study analyzes more than 2,000 patient samples, confirming the technology delivers more accurate, objective, diagnostic data than traditional testing.  January 23, 2023 —  PreciseDx, a leading innovator in AI-powered,...

PreciseDX: Leading Hospital to Study Performance of the PreciseDx Breast Test as an Aid in the Treatment Decision Process NEW YORK, Nov. 29, 2022 /PRNewswire/ -- PreciseDx, a leading AI company leveraging the analysis of morphology...

PreciseDx: In a collaboration with The Michael J. Fox Foundation, de novo study finds PreciseDx's technology can accurately diagnose Parkinson's disease in living patients prior to severe onset of symptoms NEW YORK, April 20,...